PFE · SUB~ · RS · WB P173892 · Serbia Emergency COVID-19 Response Project

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'PHARMACIA ~0.73' «MAGNA PHARMACIA» ↔ SEC PFE (CIK 78003, PFIZER INC): 1 non-competitive contracts at the buyer «WB P173892 · Serbia Emergency COVID-19 Response Project», 439,152 USD (≈ $439,152); method direct (Direct Selection); OCID WB-1842192; ⚑ REPEAT: already sanctioned SEC by FCPA (2012-08-07 Pfizer); class B: direct method prescribed by law (loan, lease, inter-agency) or pandemic emergency purchase.

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

PFE · SUB~ · RS · WB P173892 · Serbia Emergency COVID-19 Response Project

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

439,152

Records behind the indicator

1

Found

4 October 2026

Code

W-04557

Reference

WB-1842192

Reference

2012-08-07